ELI LILLY AND COMPANY et al v. SYNTHON PHARMACEUTICALS, INC.
Eli Lilly and Company and ICOS Corporation |
Synthon Pharmaceuticals, Inc. |
5:2010cv00402 |
September 23, 2010 |
US District Court for the Eastern District of North Carolina |
Western Division Office |
xxU.S. Outside District |
Malcolm J. Howard |
Patent |
35 U.S.C. ยง 271 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 64 ORDER granting 63 Motion to Substitute Party. Mylan Pharmaceuticals Inc. added. Synthon Pharmaceuticals, Inc. terminated. Signed by Chief Judge James C. Dever III on 8/1/2017. (Briggeman, N.) |
Filing 54 ORDER granting 48 Motion to Consolidate Cases: Upon consideration of the motion filed by defendants Eli Lilly and Company and ICOS Corporation for an order consolidating this action with the parallel action captioned Synthon Pharmaceuticals, Inc. v . Eli Lilly and Company and ICOS Corporation, Civil Action No. 5:10CV-00150-D, and it appearing that good cause exists for the consolidation of the cases, it is hereby ORDERED that the Motion to Consolidate is granted such that Synthon Pharmaceutical s, Inc. v. Eli Lilly and Company and ICOS Corporation, Civil Action No. 5:10-CV-OO150-D shall be consolidated with Eli Lilly and Company and ICOS Corporation v. Synthon Pharmaceuticals, Inc., Civil Action No. 5:10-CV-00402-D. Signed by Judge James C. Dever III on 11/11/2010. (Sawyer, D.) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.